Extracorporeal CO2 Removal Market to be Worth US$ 110.0 Mn by 2026, Says TMR
The link to the original content can be found at the end of our message below.
In the past Forimmediaterelease circulated releases distributed through the Cision and PR Newswire system on a complimentary basis and as a service to our readers.
PR Newswire now claims copyright on press releases distributed through the Cision and PR Newswire system.
Their pitch: “Share your brand’s story around the world,” but that’s where it ends. When eTN, as a media outlet for travel and tourism news, tried to publish a release distributed to journalists by PR Newswire, they were told the release must be removed immediately. In addition, PR Newswire threatened eTurboNews with their legal counsel claiming copyright of releases from PR Newswire or Cision circulates on behalf of clients.
Here is the letter received by eTurboNews from a PR Newswire/Cision director:
“Subject: removal request
Please immediately remove the following posting from your site: [website name removed]
PR Newswire distributed this release on behalf of our client [client name removed]
[company name removed] is understandably upset that the release is posted on your site, tagged with Travel & Tourism Industry release: at the start of the text.
As you can see below in the release that we distributed that we did not include any coding or tagging on our end to indicate that the release is relevant to the Travel & Tourism industry: [website link removed]
Please completely remove the posting from your site as soon as possible, and confirm when complete.
Additionally, I am unable to find a licensing agreement between PR Newswire and eTN, or any other associated websites. If you do have a licensing agreement in which PR Newswire has licensed your sites to publish our content, please send a copy to me as soon as possible.
If you do not have a licensing agreement, we request that you remove all PR Newswire content from all of your sites. If I should have our Counsel send an official request, please let me know to whom it should be resent.
Director CISION PR Newswire”
It appears PR Newswire is not only charging a steep amount of money from companies wanting their releases circulated through their system to journalists but also is now trying to license this content as their copyrighted material. eTN receives more than 2,000 story ideas on a daily basis, we don’t rely on PR Newswire for content, and for sure we won’t pay them a licensing fee for a ‘privilege’ to publish such content.
We urge everyone using PR Newswire services to take a look at this article explaining their modus of operation and misleading reports: http://buzz.travel/prn/ .
PR Newswire is now directly competing with publications. This will result in a drastic drop in pick-ups. They are obviously upset with the attention we received for stoties and the visibility we were able to record way ahead of PR Newswire when it comes to our industry segment.
Journalists of any publication should be warned to consider taking content from PR Newswire or Cision.
Therefore, in the future, if you would like us to consider your press releases for publication, you will need to send it to us directly: For more information, visit: www.buzz.travel .
As a courtesy to our readers, you can find the original release content at:
ALBANY, New York, May 17, 2018 /PRNewswire/ —
Transparency Market Research (TMR) has published a new report titled, “Extracorporeal CO2 Removal Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026″. According to the report, the global extracorporeal CO2 removal market was valued at US$ 50.0 Mn in 2017 and is projected to expand at a CAGR of 6.0% from 2018 to 2026. Rise in demand for innovative technologies and adoption of ECCO2R devices is expected to boost the growth of the global extracorporeal CO2 removal market from 2018 to 2026. North America and Europe are anticipated to dominate the global market during the forecast period owing to early availability of novel medical technologies, developed health care infrastructure, and increased patient awareness. Asia Pacific is expected to account for significant market share by 2026. This is attributed to large chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS) patient base in developing countries such as China and India. Rise in adoption of technologically advanced products manufactured by key manufacturers such as ALung Technologies and Xenios AG is likely to drive the global ECCO2R market.
Request to View Sample of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39602
Rise in Demand for Minimally Invasive Ventilation to Drive Market
ECCO2R technique is widely used to avoid invasive mechanical ventilation, especially in patients failing non-invasive ventilation. It also has a feasible therapeutic application to facilitate mechanical ventilation in ARDS patients. ECCO2R can be a promising adjuvant therapeutic strategy for the management of patients with severe exacerbations of COPD and to achieve protective or ultra-protective ventilation in patients with ARDS without life-threatening hypoxemia. Rise in demand for minimally invasive ventilation is anticipated to propel the extracorporeal CO2 removal market during the forecast period. Over invasive mechanical ventilation extracorporeal life support offers safer simpler respiratory applications with veno-venous support and biocompatible membranes.
Gas Exchange Units Segment Leads the Market
The report offers detailed segmentation of the global extracorporeal CO2 removal market based on product and end-user. In terms of product, the disposables segment is projected to account for leading share of the global market during the forecast period from 2018 to 2026. Extracorporeal carbon dioxide removal (ECCO2R) devices include disposables, which are used per case per patient basis. Gas exchange units are also called oxygenator/cartridges. These play an important role in effective CO2 removal. Access cannulas are also integral part of ECCO2R procedure. Factors attributed to the higher share of the disposables segment of the global market include high demand for and consumption of disposables in extracorporeal CO2 removal procedures.
Request PDF Brochure of this Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39602
Hospitals Segment Dominates the Market
The hospitals segment is projected to account for a significant share of the global extracorporeal CO2 removal market during the forecast period. The segment is anticipated to expand at a CAGR 6.0% from 2018 to 2026. Major reason responsible for the dominance of hospitals segment such as COPD & ARDS are life threatening diseases that require immediate care. Therefore, increase in number of hospital visits and rise in prevalence of COPD and ARDS are expected to boost the hospitals segment during the forecast period. The surgical centers segment is projected to hold substantial share of the global extracorporeal CO2 removal market during the forecast period. Surgical centers are well-equipped with sophisticated instruments; hence people in developing and underdeveloped countries prefer these settings.
Request for Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=39602
Significant Incremental Opportunity in North America
In terms of revenue, North America is likely to continue to dominate the global extracorporeal CO2 removal market during the forecast period, owing to early adoption of technologies and large patient pool of COPD and ARDS. The region is projected to be the most attractive market for extracorporeal CO2 removal devices, with high attractiveness index. The market in the region is expected to expand at a CAGR of 6.0% during the forecast period due to high demand for novel medical technologies. Increase in prevalence of chronic respiratory diseases and surge in demand for rapid and safe minimally invasive ventilation devices have accelerated the growth of the extracorporeal CO2 removal market in North America.
Request for Multiple Chapters: https://www.transparencymarketresearch.com/sample/sample.php?flag=MC&rep_id=39602
Highly Consolidated Market, with Key Players Accounting for Over 50.0% Share
The report also provides profiles of leading players operating in the global extracorporeal CO2 removal market. ALung Technologies, Inc., Xenios AG, Estor S.p.A., Medtronic plc, Medica S.p.A., and Getinge Group are the major players operating in the market. These players offer products with proprietary technologies, for example ALung Technologies offers proprietary products such as Hemolung RAS. Several key companies have recently introduced analytical instruments that can carry out rapid analysis in near-patient settings. Novalung is core technology platforms offered by the Xenios AG include blood extracorporeal CO2 machines, artificial lungs, temperature control, vascular access devices, and biocompatible surface.
More Trending Reports by Transparency Market Research:
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
Albany, NY – 12207
USA – Canada Toll Free: 866-552-3453
Research Blog: http://theglobalhealthnews.com/
SOURCE Transparency Market Research
To post and circulate your own press release on FIR and the eTN Network please click here
Comments are closed here.